Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 127

Similar articles for PubMed (Select 11139431)

2.

Characterization of non-peptide bradykinin B2 receptor agonist (FR 190997) and antagonist (FR 173657).

Gobeil F Jr, Montagne M, Inamura N, Regoli D.

Immunopharmacology. 1999 Sep;43(2-3):179-85.

PMID:
10596851
3.

The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.

Bellucci F, Meini S, Cucchi P, Catalani C, Giuliani S, Zappitelli S, Rotondaro L, Quartara L, Giolitti A, Maggi CA.

Eur J Pharmacol. 2004 May 3;491(2-3):121-5.

PMID:
15140628
4.

Characterization of bradykinin receptors in a human osteoblastic cell line.

Brechter AB, Lerner UH.

Regul Pept. 2002 Jan 15;103(1):39-51.

PMID:
11738247
5.

Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.

Meini S, Patacchini R, Lecci A, Quartara L, Maggi CA.

Eur J Pharmacol. 2000 Dec 8;409(2):185-94.

PMID:
11104833
6.
7.

Tumour necrosis factor-alpha enhances bradykinin-induced signal transduction via activation of Ras/Raf/MEK/MAPK in canine tracheal smooth muscle cells.

Hsu YM, Chiu CT, Wang CC, Chien CS, Luo SF, Hsiao LD, Liang KY, Yang CM.

Cell Signal. 2001 Sep;13(9):633-43.

PMID:
11495721
9.

Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: an in vitro study on human, rabbit and pig vascular B2 receptors.

Rizzi A, Rizzi C, Amadesi S, Calo' G, Varani K, Inamura N, Regoli D.

Naunyn Schmiedebergs Arch Pharmacol. 1999 Oct;360(4):361-7.

PMID:
10551272
11.

Bradykinin B2 receptor-mediated proliferation via activation of the Ras/Raf/MEK/MAPK pathway in rat vascular smooth muscle cells.

Yang CM, Chien CS, Ma YH, Hsiao LD, Lin CH, Wu C.

J Biomed Sci. 2003 Mar-Apr;10(2):208-18.

PMID:
12595757
12.
13.

Bradykinin B2 receptors and coupling mechanisms in the smooth muscle of the guinea-pig taenia caeci.

Field JL, Butt SK, Morton IK, Hall JM.

Br J Pharmacol. 1994 Oct;113(2):607-13.

14.

Pharmacological characterization of a nonpeptide bradykinin B2 receptor antagonist, FR165649, and agonist, FR190997.

Asano M, Hatori C, Sawai H, Johki S, Inamura N, Kayakiri H, Satoh S, Abe Y, Inoue T, Sawada Y, Mizutani T, Oku T, Nakahara K.

Br J Pharmacol. 1998 Jun;124(3):441-6.

15.

Kinin B1 and B2 receptors in pig vessels: characterization of two monoreceptor systems.

Rizzi A, Calò G, Amadesi S, Regoli D.

Naunyn Schmiedebergs Arch Pharmacol. 1997 Nov;356(5):662-70.

PMID:
9402047
16.

Characterization of bradykinin receptors in canine cultured corneal epithelial cells: pharmacological and functional studies.

Huang SC, Hsiao LD, Chien CS, Wang CC, Chiu CT, Tsai RJ, Yang CM.

J Biomed Sci. 2002 May-Jun;9(3):213-22.

PMID:
12065896
17.
18.
20.

Inflammation modifies the role of cyclooxygenases in the contractile responses of the rat detrusor smooth muscle to kinin agonists.

Meini S, Lecci A, Cucchi P, Catalioto RM, Criscuoli M, Maggi CA.

J Pharmacol Exp Ther. 1998 Oct;287(1):137-43.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk